RA Capital Management reports USD 412,776 Artiva Biotherapeutics common share purchase - ARTV News | RalliesRA Capital Management reports USD 412,776 Artiva Biotherapeutics common share purchase
A
ARTV• RA Capital Management reports open-market share purchase
- RA Capital Management, a director-level 10% owner, reported an open-market purchase of 41,319 Artiva Biotherapeutics common shares.
- Purchase price reported at USD 9.99 per share.
- Beneficial ownership reported at 17,283,802 shares following the transaction.
